Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zectivimod in moderate to severe ulcerative colitis
NCT04096573Phase 2Withdrawn
- Sponsor
- LG Chem
- Start
- Apr 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of zectivimod in ulcerative colitis (UC), sponsored by LG Chem. Planned start Apr 2020; status: withdrawn.
02
Drugs
zectivimod
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT04096573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04096573.